Christian Tientcha Happi | Professor of Molecular Biology and Genomics in the Department of Biological Sciences & Director
ACEGID
Christian Happi, is a Professor of Molecular Biology and Genomics and Director of the World Bank funded African Center of Excellence for Genomics of infectious Diseases, (ACEGID), Redeemer’s University, Ede, Nigeria. He did his postdoctoral fellowship at Harvard University (2000-2003), and worked there as a Research Scientist (2004-2007). He is currently Adjunct Professor in the Department of Immunology and Infectious Diseases, Harvard T H Chan School of Public Health, Boston, USA. Professor Happi used next generation sequencing technology to perform the first sequence of the SARS-CoV-2 in Africa, within 48 hours of receiving sample of the first case in Nigeria. This seminal work not only provided an insight into the detailed genetic map of the coronavirus in Africa, but also paved the way to the development of new countermeasures including new diagnostics, therapeutics and vaccines. He received the Merle A. Sande Health Leadership Award (2011); the 2019 Human Genome Organization Africa Prize for his seminal work on infectious diseases genomics in Africa; the 2020 Bailey K. Ashford Medal by the American Society of Tropical Medicine and Hygiene. In 2021, he received the Al-Sumait Prize for African Development of the Kuwait Foundation for Advancement in Sciences. He is a Fellow of the Nigerian Academy of Sciences, A Fellow of Academy of Medical Specialties of Nigeria, and he is a member of the US National Academy of Medicine.
Appearances:
Pre-Congress Workshops - 21st April @ 10:00
BIODEFENSE
Protecting public health from biothreats to pandemics.
- What is the progress on new technologies in medical product development?
- How our governments are incentivizing (portfolio approach), especially with biotech and industry? What International collaborations are being facilitated?
How our governments are incentivizing (portfolio approach), especially with biotech and industry?
10:10 Melinda Hamer, Operating Partner, GHIC
10:30 BARDA & Sabin: Kelly Warfield, Sabin Vaccine Institute’s President of Research & Development, Sabin Institute
10:50 – 11:50 Panel: Collaboration with industry: the solution for a sustainable posture for biodefence and global health security
Col Matt Clark, Joint Project Manager, CBRN, JPEO-CBRND
Kevin Webb, COO, API Innovation Center
Chan Harjivan, Former Assistant at The White House & Chief Strategy Officer, The Medical Countermeasures Coalition
11:50 – 12:50 Panel: Rapid vaccine development through manufacturing innovation
Moderator: Praneel Jadav, Manager, Infectious Disease Policy, BIO
Mike Stebbins, Manufacturing and Threat Countermeasures Division, ATI
Renee Hart, President & CBO, LumaCyte
Lakshmi Krishnan, Vice President of Research, National Research Council of Canada
1:00 - 2:00 break
2:00 – 3:10 Panel: What are the remaining bottlenecks holding us back from achieving the 100 day mission?
Moderator: Dr Philip Krause, Independent Consultant & Former FDA
William Falstich, VP, Primary Care Category Supply Chain Lead, Pfizer
Dr Bassam Hallis, Deputy Director, Vaccine Development & Evaluation Centre, UKHSA
Dr Seth Berkley, Former CEO, Gavi; Senior Advisor, Pandemic Center at Brown University
Marion Gruber, Vice President, Public Health and Regulatory Affairs, IAVI
Kent Kester, Executive Director, Vaccine Research and Development, CEPI
3:10 – 4:10 Panel: International pandemic funding – how can we make it accessible globally?
Moderator: Soazic Elise Wang Sonn, Economist, World Bank Group, Washington D.C.
Dr Seth Berkley, Former CEO, Gavi; Senior Advisor, Pandemic Center at Brown University
Dr Christian Tientcha Happi, Professor of Molecular Biology and Genomics in the Department of Biological Sciences & Director, African Center of Excellence for Genomics of Infectious Diseases (ACEGID)
Megan Rauscher, Senior Manager, Private Sector Program Lead, ThinkWell
Dr Monique K Mansoura, Executive Director, Global Health Security & Biotechnology, Independent
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events